Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6304818rdf:typepubmed:Citationlld:pubmed
pubmed-article:6304818lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6304818lifeskim:mentionsumls-concept:C0008013lld:lifeskim
pubmed-article:6304818lifeskim:mentionsumls-concept:C0023546lld:lifeskim
pubmed-article:6304818lifeskim:mentionsumls-concept:C1762617lld:lifeskim
pubmed-article:6304818lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:6304818lifeskim:mentionsumls-concept:C2612881lld:lifeskim
pubmed-article:6304818pubmed:issue2lld:pubmed
pubmed-article:6304818pubmed:dateCreated1983-7-8lld:pubmed
pubmed-article:6304818pubmed:abstractTextWe have examined the effects of very pure (greater than 99.8%) chemically synthesized leukotriene B4 of verified structure on the chemotactic and secretory behavior of human polymorphonuclear leukocytes (PMN). The synthetic material is highly chemotactic and shows the same concentration dependence of this activity as does natural LTB4. Synthetic LTB4 is also a weak degranulating agent in cytochalasin B treated PMN. Maximally it released 11%, 17% and 26% as much N-acetyl-beta-D-glucosaminidase, myeloperoxidase and lysozyme as did N-formyl-methionine-leucine-phenylalanine (fMLP). Thus LTB4 differs significantly from other chemotaxins, such as C5a and fMLP, in that it is a poor secretagogue for enzymes of the specific and azurophilic granules of human PMN.lld:pubmed
pubmed-article:6304818pubmed:languageenglld:pubmed
pubmed-article:6304818pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6304818pubmed:citationSubsetIMlld:pubmed
pubmed-article:6304818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6304818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6304818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6304818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6304818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6304818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6304818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6304818pubmed:statusMEDLINElld:pubmed
pubmed-article:6304818pubmed:monthFeblld:pubmed
pubmed-article:6304818pubmed:issn0090-6980lld:pubmed
pubmed-article:6304818pubmed:authorpubmed-author:LauC KCKlld:pubmed
pubmed-article:6304818pubmed:authorpubmed-author:ZamboniRRlld:pubmed
pubmed-article:6304818pubmed:authorpubmed-author:ZanolariBBlld:pubmed
pubmed-article:6304818pubmed:authorpubmed-author:RokachJJlld:pubmed
pubmed-article:6304818pubmed:authorpubmed-author:SpringerM SMSlld:pubmed
pubmed-article:6304818pubmed:authorpubmed-author:RollinsT ETElld:pubmed
pubmed-article:6304818pubmed:authorpubmed-author:GuindonYYlld:pubmed
pubmed-article:6304818pubmed:issnTypePrintlld:pubmed
pubmed-article:6304818pubmed:volume25lld:pubmed
pubmed-article:6304818pubmed:ownerNLMlld:pubmed
pubmed-article:6304818pubmed:authorsCompleteYlld:pubmed
pubmed-article:6304818pubmed:pagination281-9lld:pubmed
pubmed-article:6304818pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:6304818pubmed:meshHeadingpubmed-meshheading:6304818-...lld:pubmed
pubmed-article:6304818pubmed:meshHeadingpubmed-meshheading:6304818-...lld:pubmed
pubmed-article:6304818pubmed:meshHeadingpubmed-meshheading:6304818-...lld:pubmed
pubmed-article:6304818pubmed:meshHeadingpubmed-meshheading:6304818-...lld:pubmed
pubmed-article:6304818pubmed:meshHeadingpubmed-meshheading:6304818-...lld:pubmed
pubmed-article:6304818pubmed:meshHeadingpubmed-meshheading:6304818-...lld:pubmed
pubmed-article:6304818pubmed:meshHeadingpubmed-meshheading:6304818-...lld:pubmed
pubmed-article:6304818pubmed:meshHeadingpubmed-meshheading:6304818-...lld:pubmed
pubmed-article:6304818pubmed:meshHeadingpubmed-meshheading:6304818-...lld:pubmed
pubmed-article:6304818pubmed:meshHeadingpubmed-meshheading:6304818-...lld:pubmed
pubmed-article:6304818pubmed:meshHeadingpubmed-meshheading:6304818-...lld:pubmed
pubmed-article:6304818pubmed:meshHeadingpubmed-meshheading:6304818-...lld:pubmed
pubmed-article:6304818pubmed:year1983lld:pubmed
pubmed-article:6304818pubmed:articleTitleSynthetic leukotriene B4 is a potent chemotaxin but a weak secretagogue for human PMN.lld:pubmed
pubmed-article:6304818pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6304818pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6304818lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6304818lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6304818lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6304818lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6304818lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6304818lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6304818lld:pubmed